Skip to main content

Table 3 Summary of articles meeting the inclusion criteria

From: Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis

Author & Publication Year (Reference)

Study Population

Age [years]

# Subjects (# Titers)

Days Post- Exposure

Neut. %

DENV1 strains

DENV2 strains

DENV3 strains

DENV4 strains

Natural Exposure Studies

Russell et al. 1967 [19]

Thailand, USA

children, adults

7 (28)

17-28

50

--

--

--

--

Sukhavachana et al. 1969 [20]

--

--

2 (16)

7, 14

50

Hawaii

New Guinea C

H87

H241

Scott et al. 1972 [21]

Puerto Rico

--

3 (11)

11-20

50

Hawaii

PR-109

H87

23751

Russell and McCown 1972 [22]

Puerto Rico, Tahiti

--

5 (30)

21

50

n/a

n/a

H87, 21153, PR-6, PR-38, J-1007, Tahiti-4

n/a

Halstead 1974 [23]*

USA

adults

9 (36)

15341-17532

50

16007

16681

16562

4328-S

Papaevangelou and Halstead 1977 [24]*

Greece

adults

45 (180)

16436

50

16007

16681

16562

4328S

Fujita and Yoshida 1979 [25]

Japan

45-74

9 (36)

12419

50

Mochizuki, Hawaii

Trinidad 1751

H87

H241

Scott et al. 1976 [26]

Thailand

children

6 (48)

3-67

50

--

--

--

--

van Peenen et al. 1978 [27]

Indonesia

1-18

4 (32)

7, 14

--

--

--

--

--

Okuno et al. 1980 [28]*

Thailand

1-13

20 (160)

1-13

50

Hawaii

New Guinea B

H87

H241

Fukunaga et al. 1983 [29]*

Japan

28-55

9 (36)

2-13

50

Hawaii

New Guinea B

H87

H241

Okuno et al. 1983 [30]

Japan

adults

11 (51)

1826-14610

--

Hawaii, Mochizuki

New Guinea B

H87

H241

Sangkawibha et al. 1984 [15]*

Thailand

1-8

8 (60)

0-17

50

16007

16681

16562

4328-S

Morens et al. 1985 [31]

Puerto Rico

--

24 (267)

0-70

50 & 70

CV.1636 / 77

PR-159

PR-6

n/a

Rosen 1986 [32]*

Greece, Pacific Islands, USA

42-60

68 (268)

7-16436

90

Hawaii

New Guinea C

H87

H241

Kliks et al. 1989 [33]*

Thailand

children

10 (40)

0

50

--

D80-616

--

--

Kuno et al. 1993 [34]

Puerto Rico

4-50

9 (79)

0-83

50

--

--

--

--

Graham et al. 1999 [35]*

Indonesia

4-9

17 (131)

0, 10-361

70

16007

16681

16562

1009

Yamada et al. 2003 [36]

Japan

--

37 (71)

2-44

50

--

--

--

--

Alvarez et al. 2006 [37]*

Cuba

--

43 (371)

3-21, 517-834

50

Angola

A15/81, I348600

116/00

Dominica / 814669

Alvarez et al. 2008 [38]*

Cuba

--

20 (140)

515

50

n/a

n/a

116/00, 118/00, 140/00, 167/01, 557/01, 21/02, Puerto Rico

n/a

Lai et al. 2008 [39]*

Taiwan

--

7 (32)

7-14

70

Hawaii

New Guinea C

H87

H241

da Silva-Nunes et al. 2008 [40]

Brazil

5-90

20 (120)

0, 274

50

--

--

--

n/a

Crill et al. 2009 [41]*

Taiwan, Puerto Rico

--

12 (48)

6-18

80

56BC94 / 95

16681

116RC1396

H241

Vaccination Studies

Summers et al. 1984 [42]*

USA

--

8 (16)

30, 180

50

n/a

PR-159

n/a

n/a

Rabablert et al. 2000 [43]*

Thailand

18-35

8 (64)

0, 60

--

16007

16681

16562

1036

Rothman et al. 2001 [44]

USA

--

6 (48)

60, 180

80

Hawaii

New Guinea C

CH53489

Dominica / 814669

Kanesa-Thasan et al. 2003 [45]*

USA

18-49

20 (397)

0, 28, 60, 120, 180

50

--

--

--

--

Guy et al. 2004 [46]

Thailand

4-14

16 (128)

273, 2009

50

16007

16681

16562

1036

Kitchener et al. 2006 [47]

Australia

21-39

10 (40)

42

50

--

--

--

--

Vasilakis et al. 2008 [18]*^

USA, unknown location

18-50

61 (719)

42 vacc, 16 infect

80

OBS7690, P72-1244

16681, 1349, IQT1950, 1328, P8-1407, DakArA510, DakArA1247, DakArA2022

FSP-032

H241, P75-125

Sun et al. 2009 [48]

USA

18-45

71 (704)

28, 180, 208

50

45AZ5

S16803

CH53489

341750

  1. “Neut. %” indicates neutralization percentage; “DENV#” indicates dengue virus serotype; “—” indicates unreported data; “n/a” indicates serotype was not tested, ^ indicates article contains titers from vaccination and infection studies, * indicates article was included in the pooled analysis.